Nobuhiko Seki Maika Natsume Ryosuke Ochiai Terunobu Haruyama Masashi Ishihara Yoko Fukasawa Takahiko Sakamoto Shigeru Tanzawa Ryo Usui Takeshi Honda Shuji Ota Yasuko Ichikawa Kiyotaka Watanabe
10.1159/000493088
Case Rep Oncol
2019 Jan 21;12(1):91-97.
bevacizumab egfr mutation erlotinib lung cancer met amplification
CC BY-NC
https://pubmed.ncbi.nlm.nih.gov/30792648/
Case Reports
PMC6381877
30792648
Promising Combination Therapy with Bevacizumab and Erlotinib in an EGFR-Mutated NSCLC Patient with MET Amplification Who Showed Intrinsic Resistance to Initial EGFR-TKI Therapy
2019